Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Naive”

1,092 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,092 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Testing effectiveness (Phase 2)Study completedNCT00807625
What this trial is testing

Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia

Who this might be right for
HIVContraceptionHIV Infections
University of Alabama at Birmingham 66
Testing effectiveness (Phase 2)Study completedNCT01581138
What this trial is testing

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 64
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Testing effectiveness (Phase 2)UnknownNCT00332176
What this trial is testing

Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
BioWest Therapeutics Inc 50
Not applicableStudy completedNCT03873974
What this trial is testing

Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis

Who this might be right for
Lyme Borreliosis
Lyme Diagnostics Ltd. 400
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Post-approval studies (Phase 4)Study completedNCT01736761
What this trial is testing

A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.

Who this might be right for
HIV
St Stephens Aids Trust 36
Post-approval studies (Phase 4)Study completedNCT00107653
What this trial is testing

Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 569
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Testing effectiveness (Phase 2)UnknownNCT05100303
What this trial is testing

Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 58
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Post-approval studies (Phase 4)Study completedNCT00442962
What this trial is testing

HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 54
Not applicableEnded earlyNCT00146094
What this trial is testing

Bone Mineral Density (BMD) in HIV Infection

Who this might be right for
OsteopeniaOsteoporosis
University Hospital, Strasbourg, France 44
Testing effectiveness (Phase 2)Study completedNCT04463953
What this trial is testing

Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 25
Testing effectiveness (Phase 2)Study completedNCT01338883
What this trial is testing

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 143
Testing effectiveness (Phase 2)Study completedNCT00827112
What this trial is testing

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus-1
ViiV Healthcare 129
Not applicableUnknownNCT04180865
What this trial is testing

The Dutch Parkinson and Cognition Study

Who this might be right for
Parkinson Disease
University Medical Center Groningen 150
Not applicableStudy completedNCT00575939
What this trial is testing

Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV

Who this might be right for
HIV InfectionsAtherosclerosis
University Hospitals Cleveland Medical Center 120
Large-scale testing (Phase 3)Study completedNCT01257451
What this trial is testing

Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes Mellitus
Novartis Pharmaceuticals 431
Load More Results